Quantcast

Latest Attention-deficit hyperactivity disorder controversies Stories

2010-05-21 08:15:00

NEW ORLEANS, May 21 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced new findings on once-daily INTUNIV(TM) (guanfacine) Extended Release Tablets, the first selective alpha-2A agonist approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD), at a major psychiatric meeting. The primary objective of this study was to evaluate the efficacy of INTUNIV, dosed either in the morning or evening...

2010-05-17 11:11:35

University of Montreal and Harvard scientists publish study in Pediatrics A team of scientists from the University of Montreal and Harvard University have discovered that exposure to organophosphate pesticides is associated with increased risk of Attention-Deficit Hyperactivity Disorder (ADHD) in children. Published in the journal Pediatrics, the investigation found a connection between exposure pesticides and the presence of symptoms of ADHD. The study focused on 1,139 children from the...

2010-05-13 08:39:32

Several barriers prevent minority children with ADHD from receiving the most effective treatments, according to a new study by Michigan State University researchers. In the May issue of the Journal of Attention Disorders, the researchers argue schools and communities should do a better job of getting information to minority families about the combined benefit of medication and counseling for attention deficit hyperactivity disorder. "ADHD has multiple causes and multiple treatment approaches...

2010-05-04 11:48:13

Children with ADHD who carry a specific type of dopamine receptor gene respond better to the drug methylphenidate (MPH) than those without the genotype, according to new research from Cincinnati Children's Hospital Medical Center. The findings come from the first-ever placebo-controlled pharmacogenetic drug trial for Attention Deficit/Hyperactivity Disorder in school age children to evaluate variants of the DRD4 dopamine receptor gene using teacher ratings of children's symptoms. The research...

2010-05-04 08:15:00

PHILADELPHIA, May 4 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved a change to the prescribing information for its once-daily Attention Deficit Hyperactivity Disorder (ADHD) treatment Vyvanse® (lisdexamfetamine dimesylate) Capsules CII, to include supplemental data demonstrating significant improvement in attention in adults with ADHD...

2010-05-03 07:48:58

Study shows 60 percent of children ages 11 and older take at least 1 medication Behavioral interventions typically are the first line of treatment to manage unwanted behaviors in children with autism spectrum disorders (ASDs). If behaviors do not improve, medications frequently are added to the mix. Research conducted by Autism Speaks' Autism Treatment Network (ATN) shows that use of psychotropic medications is common among children with ASD, with 27 percent of those enrolled in the network...

2010-04-15 13:02:50

Medication and behavioral interventions help children with Attention Deficit Hyperactivity Disorder (ADHD) better maintain attention and self control by normalizing activity in the same brain systems, according to researchers at The University of Nottingham. In a study, funded by the Wellcome Trust and published today in the journal Biological Psychiatry, researchers led by Chris Hollis, Professor of Child and Adolescent Psychiatry, in the School of Community Health Sciences, have shown that...

2010-04-05 04:00:00

PORTLAND, Ore., April 5 /PRNewswire/ -- High school students who struggle with Attention Deficit Hyperactivity Disorder (ADHD) may only be a click away from a helpful alternative option. Insight Schools, a national network of accredited, tuition-free online public high schools, finds many of its students diagnosed with the disorder are thriving in its personalized, flexible learning environment. According to the US Department of Health and Human Services, 2.4 million children between the...

2010-03-31 11:28:49

Mount Sinai researchers have learned that meta-cognitive therapy (MCT), a method of skills teaching by use of cognitive-behavioral principles, yielded significantly greater improvements in symptoms of attention deficit hyperactivity disorder (ADHD) in adults than those that participate in supportive therapy. The study, titled "Meta-Cognitive Therapy," is now published in the American Journal of Psychiatry. Mary Solanto, Ph.D., Associate Professor in the Department of Psychiatry and Director...

2010-02-17 15:21:00

BRENTWOOD, Tenn., Feb. 17 /PRNewswire/ -- The Learning Lab of Brentwood will present a free seminar, Tips for Parenting ADHD Kids, on Thursday February 25 from 12:00-1:30 PM at the Community Services Building in Franklin. Dr. David Elkins, Clinical Psychologist and Supervising Psychologist of the Assessment Center at The Learning Lab of Brentwood, will lead the seminar. "Any parent with an ADHD child knows the daily challenges can often seem overwhelming," said Pat Elkins, Director of The...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related